Bronchopulmonary dysplasia is the major sequela of respiratory distress syndrome (RDS) premature infants. Although it is clear that RDS is mainly due to the deficiency of lung surfactant, the mechanisms of the development of BPD remain poorly defined. Recently, we purified two Ca2+ - dependent phospholipid binding proteins (PLBPs) from rabbit lung. These proteins are found in alveolar type II cells and the lining layers of alveoli and larger airways, and they preferentially fuse vesicles to surfactant membranes. Our observations suggest that PLBPs may play an important role in surfactant biogenesis. Thus, if there is any deficiency of these proteins in lung, this may be associated with the development of RDS and/or BPD. These hypotheses will be tested by the following proposed experiments: (1) determine PLBPs in developing lungs and investigate the effects of steroids and hyperoxia on these proteins during lung growth; (2) investigate the relationship between PLBPs and the development of RDS and BPD; (3) study in vitro protein synthesis and post-translation modifications of PLBPs for better understanding the structure-function relationships of these proteins; (4) investigate the role and regulation of PLBPs in type II cells in relationship to surfactant metabolism; (5) study the mechanisms of binding of PLBPs with Ca2+, phospholipids and surfactant membranes for better understanding the protein's binding actions and the protein's preferential binding with surfactant membranes. These studies will provide important information for understanding the relationship between lung PLBPS, surfactant biogenesis and the development of RDS and BPD. Data from these studies may also prove useful for designing novel treatment for RDS and BPD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL046478-04
Application #
3736899
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Grummer, M A; Zachman, R D (1998) Retinoic acid and dexamethasone affect RAR-beta and surfactant protein C mRNA in the MLE lung cell line. Am J Physiol 274:L1-7
Tsao, F H; Meyer, K C; Chen, X et al. (1998) Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis. Am J Respir Cell Mol Biol 18:120-8
Zimmerman, J J; Gabbert, D; Shivpuri, C et al. (1998) Meter-dosed, inhaled beclomethasone attenuates bronchoalveolar oxyradical inflammation in premature infants at risk for bronchopulmonary dysplasia. Am J Perinatol 15:567-76
Zachman, R D; Grummer, M A (1998) Effect of maternal/fetal vitamin A deficiency on fetal rat lung surfactant protein expression and the response to prenatal dexamethasone. Pediatr Res 43:178-83
Ts'ao, C; Ward, W F; Molteni, A et al. (1997) Annexin I concentration and prostacyclin production in rat lung and alveolar macrophages following irradiation. Prostaglandins Leukot Essent Fatty Acids 56:99-104
Zimmerman, J J; Ciesielski, W; Lewandoski, J (1997) Neutrophil-mediated phospholipid peroxidation assessed by gas chromatography-mass spectroscopy. Am J Physiol 273:C653-61
Contreras, M; Hariharan, N; Lewandoski, J R et al. (1996) Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 24:29-37
Tsao, F H; Cheng, W; Chen, X et al. (1996) Isolation and sequencing of the cDNA encoding phosphatidylinositol transfer protein from rabbit lung. Gene 172:299-302
Zachman, R D; Samuels, D P; Brand, J M et al. (1996) Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants. Am J Clin Nutr 63:123-9
Zimmerman, J J (1995) Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 22:429-56

Showing the most recent 10 out of 18 publications